+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Keratinocyte Growth Factor Market by Type, Form, Route of Administration, Application, End-User - Global Forecast to 2030- Product Image
Keratinocyte Growth Factor Market by Type, Form, Route of Administration, Application, End-User - Global Forecast to 2030- Product Image
Sale

Keratinocyte Growth Factor Market by Type, Form, Route of Administration, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055220
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The keratinocyte growth factor (KGF) market is progressing rapidly, powered by strong advances in molecular biology and increasing demand across therapeutic, cosmetic, and research applications. Senior decision-makers are confronting both fresh growth avenues and evolving complexity as innovative delivery systems, regulatory dynamics, and supply chain shifts redefine the industry landscape.

Market Snapshot: Keratinocyte Growth Factor Market

The Keratinocyte Growth Factor Market grew from USD 142.33 million in 2024 to USD 152.78 million in 2025. It is expected to continue growing at a CAGR of 7.50%, reaching USD 219.68 million by 2030. This positive trajectory stems from ongoing breakthroughs in recombinant bioprocessing, expanding clinical and cosmetic applications, and shifting global regulatory environments. North America, Europe, and Asia-Pacific are chief engines of adoption, reflecting robust clinical research, commercial initiatives, and regional policy changes. Stakeholders in biotechnology, pharma, healthcare delivery, and research organizations are tracking this expansion to harness diverse opportunities within the broader biopharmaceutical ecosystem.

Scope & Segmentation: Unpacking KGF’s Full Market Landscape

This report provides a granular analysis of the market, mapping the entire KGF value chain and identifying high-impact segments and geographies:

  • Type: Endogenous variants (autologous expression), recombinant products (scalable biomanufacturing)
  • Form: Liquid preparations, powder/lyophilized options for extended shelf-life
  • Route of Administration: Parenteral methods (intratracheal, intravenous, subcutaneous), topical solutions (creams, gels)
  • Application: Cosmetics (anti-aging, hair care), research & development, therapeutics (oncology, gastrointestinal disorders, wound healing)
  • End-User: Hospitals and specialty clinics, pharmaceutical and biotechnology firms, research institutes
  • Region: Americas (United States, Canada, Latin America), Europe, Middle East & Africa (multiple key markets), Asia-Pacific (China, Japan, South Korea, regional players)
  • Key Companies: Leading entities include major biopharmaceuticals, innovative biotechs, and specialist suppliers, each contributing to competitive and technological evolution

Key Takeaways: Strategic Insights for the KGF Industry

  • Recombinant expression systems now play a principal role in scaling production and refining safety profiles for KGF-based solutions.
  • Clinical adoption expands across advanced wound care and dermatology, with hair-care cosmetics and anti-aging topical formulations gaining commercial momentum.
  • Personalized medicine approaches are strengthening, leveraging the regenerative capacities of KGF in combination therapies and tailored dosing regimens.
  • Collaborations between contract development organizations, academic centers, and pharmaceutical manufacturers are intensifying, fueling innovation and accelerating product launches.
  • Digital integration—such as AI-guided process optimization and remote monitoring—supports cost containment and improves clinical outcomes within KGF development initiatives.
  • Local regulatory nuances, reimbursement climates, and region-specific infrastructure investments are increasingly influencing competitive strategies and market entry timing.

Tariff Impact: Navigating Trade-Related Disruptions

Recent U.S. tariff adjustments affecting biologic intermediates and delivery components have increased raw material costs for KGF production. This has led manufacturers to reevaluate sourcing strategies, enhance local supply chains, and cultivate relationships with domestic and regional suppliers. Some firms turn to tariff-exempt trade zones and strategic alliances to ease margin pressures. Downstream, hospitals and clinics face incremental pricing changes, while pharmaceutical players are optimizing costing models and revisiting manufacturing footprints. Continued engagement with policymakers and diversified procurement are central to mitigating ongoing tariff risks.

Methodology & Data Sources

Findings are derived from rigorous secondary research (peer-reviewed literature, regulatory documentation, patent databases, financial disclosures) and primary interviews with industry experts, executives, and clinical thought leaders. Data triangulation and double-blind quality checks underpin the analysis, ensuring reliable, defensible insights for decision-making.

Why This Report Matters

  • Enables executives to identify the most commercially attractive segments and regions, aligning resources with market demand.
  • Delivers actionable intelligence to mitigate regulatory, supply chain, and trade-related risks in a volatile landscape.
  • Equips stakeholders to benchmark their competitive positioning and pursue strategic partnerships for future growth.

Conclusion

The keratinocyte growth factor market is evolving swiftly as technology, trade policy, and end-user demand intersect. A clear understanding of segment dynamics, regional variations, and innovation drivers will support confident, forward-looking decisions for senior leaders.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Keratinocyte Growth Factor Market, by Type
8.1. Introduction
8.2. Endogenous
8.3. Recombinant
9. Keratinocyte Growth Factor Market, by Form
9.1. Introduction
9.2. Liquid
9.3. Powder
10. Keratinocyte Growth Factor Market, by Route of Administration
10.1. Introduction
10.2. Parenteral
10.2.1. Intratracheal
10.2.2. Intravenous
10.2.3. Subcutaneous
10.3. Topical Solutions
11. Keratinocyte Growth Factor Market, by Application
11.1. Introduction
11.2. Cosmetics
11.2.1. Anti-Aging Products
11.2.2. Hair Care
11.3. Research & Development
11.4. Therapeutics
11.4.1. Cancer Treatment
11.4.2. Gastrointestinal Disorders
11.4.3. Skin Wound Healing
12. Keratinocyte Growth Factor Market, by End-User
12.1. Introduction
12.2. Hospitals & Specialty Clinics
12.3. Pharmaceutical & Biotechnology Companies
12.4. Research Institutes
13. Americas Keratinocyte Growth Factor Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Keratinocyte Growth Factor Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Keratinocyte Growth Factor Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbexa Ltd
16.3.2. Abcam Limited.
16.3.3. ACROBiosystems.com
16.3.4. Amgen Inc.
16.3.5. Applied Biological Materials Inc.
16.3.6. Biorbyt Ltd.
16.3.7. BioVendor R&D
16.3.8. BPS Bioscience, Inc.
16.3.9. CliniSciences S.A.S
16.3.10. CUSABIO TECHNOLOGY LLC
16.3.11. Elabscience Bionovation Inc.
16.3.12. Eli Lilly and Company
16.3.13. FUJIFILM Wako Pure Chemical Corporation
16.3.14. Krishgen Biosystems
16.3.15. LifeSpan BioSciences, Inc
16.3.16. Merck KGaA
16.3.17. MyBioSource, Inc.
16.3.18. NAMIKI SHOJI Co., Ltd.
16.3.19. PromoCell GmbH
16.3.20. Prospec-Tany Technogene Ltd.
16.3.21. R&D Systems, Inc.
16.3.22. RayBiotech, Inc.
16.3.23. ScienCell Research Laboratories, Inc.
16.3.24. STEMCELL Technologies
16.3.25. Takeda Pharmaceutical Company Limited.
16.3.26. Thermo Fisher Scientific Inc.
16.3.27. VWR International, LLC.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. KERATINOCYTE GROWTH FACTOR MARKET MULTI-CURRENCY
FIGURE 2. KERATINOCYTE GROWTH FACTOR MARKET MULTI-LANGUAGE
FIGURE 3. KERATINOCYTE GROWTH FACTOR MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. KERATINOCYTE GROWTH FACTOR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. KERATINOCYTE GROWTH FACTOR MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. KERATINOCYTE GROWTH FACTOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ENDOGENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY INTRATRACHEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TOPICAL SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ANTI-AGING PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY SKIN WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY HOSPITALS & SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 54. CANADA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. CANADA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 56. CANADA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. CANADA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 58. CANADA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 59. CANADA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. MEXICO KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 62. MEXICO KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. MEXICO KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 67. MEXICO KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. GERMANY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 103. GERMANY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. GERMANY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. GERMANY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 107. GERMANY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 108. GERMANY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. FRANCE KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. FRANCE KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. FRANCE KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. FRANCE KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 115. FRANCE KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 116. FRANCE KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. ITALY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 127. ITALY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 129. ITALY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ITALY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 131. ITALY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 132. ITALY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SPAIN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 135. SPAIN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. SPAIN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 137. SPAIN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SPAIN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 139. SPAIN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 140. SPAIN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. DENMARK KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. DENMARK KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 167. DENMARK KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. DENMARK KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 169. DENMARK KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. DENMARK KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 171. DENMARK KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 172. DENMARK KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. QATAR KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 183. QATAR KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 185. QATAR KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 187. QATAR KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 188. QATAR KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. FINLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 191. FINLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. FINLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 193. FINLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 196. FINLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. EGYPT KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 215. EGYPT KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. EGYPT KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. EGYPT KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 219. EGYPT KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 220. EGYPT KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 223. TURKEY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. TURKEY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 227. TURKEY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 228. TURKEY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 237. NORWAY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. NORWAY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 239. NORWAY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. NORWAY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 241. NORWAY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. NORWAY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 243. NORWAY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. POLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. POLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 247. POLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. POLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 249. POLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 251. POLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 252. POLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 270. CHINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 271. CHINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 272. CHINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. CHINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 274. CHINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. CHINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 276. CHINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 277. CHINA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. INDIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 280. INDIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. INDIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 282. INDIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. INDIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 284. INDIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 285. INDIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 286. JAPAN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 288. JAPAN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. JAPAN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. JAPAN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 293. JAPAN KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 318. THAILAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 319. THAILAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 320. THAILAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. THAILAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY PARENTERAL, 2018-2030 (USD MILLION)
TABLE 322. THAILAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. THAILAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 324. THAILAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 325. THAILAND KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES KERATINOCYTE GROWTH FACTOR MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-203

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Keratinocyte Growth Factor market report include:
  • Abbexa Ltd
  • Abcam Limited.
  • ACROBiosystems.com
  • Amgen Inc.
  • Applied Biological Materials Inc.
  • Biorbyt Ltd.
  • BioVendor R&D
  • BPS Bioscience, Inc.
  • CliniSciences S.A.S
  • CUSABIO TECHNOLOGY LLC
  • Elabscience Bionovation Inc.
  • Eli Lilly and Company
  • FUJIFILM Wako Pure Chemical Corporation
  • Krishgen Biosystems
  • LifeSpan BioSciences, Inc
  • Merck KGaA
  • MyBioSource, Inc.
  • NAMIKI SHOJI Co., Ltd.
  • PromoCell GmbH
  • Prospec-Tany Technogene Ltd.
  • R&D Systems, Inc.
  • RayBiotech, Inc.
  • ScienCell Research Laboratories, Inc.
  • STEMCELL Technologies
  • Takeda Pharmaceutical Company Limited.
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC.

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 152.78 Million
Forecasted Market Value ( USD ) by 2030 $ 219.68 Million
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Reports

3D Reconstructed Human Epidermis Model Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

3D Reconstructed Human Epidermis Model Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
StrataGraft Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

StrataGraft Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Induced Pluripotent Stem Cell (IPSC) Market Report 2025 - Product Image

Induced Pluripotent Stem Cell (IPSC) Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025 - Product Image

Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • 150 Pages
  • Global
From
Induced Pluripotent Stem Cells Market Size, Share & Trends Analysis Report By Derived Cell Type (Hepatocytes, Fibroblasts), By Application (Drug Development), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Induced Pluripotent Stem Cells Market Size, Share & Trends Analysis Report By Derived Cell Type (Hepatocytes, Fibroblasts), By Application (Drug Development), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.